Frontlight ResearchEarly access
Prostate cancer trials in United States
554 of 656 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleSafety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Where
- Duarte, Fairfax, Houston, Irvine, Orange, Palo Alto, San Francisco, Seattle, Zion
- Age
- 18 years and over
- People
- 347 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05997615 · EU 2023-503495-24-00 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Baltimore, Buffalo, Chicago, Duarte, Houston, Kissimmee, Nashville, New Haven, New York, Rockville, Saint Louis Park, Saint Paul, Seattle, St Louis
- Age
- 18 years and over
- People
- 890 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 3Taking peopleA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
- Where
- Albany, Atlanta, Aurora, Austin, Cincinnati, Fairfax, Fort Myers, Houston, Myrtle Beach, Nashville, Niles, Norfolk, Peoria, Rockville, Santa Barbara, St. Petersburg, Tucson, Tyler, West Palm Beach, White Plains, Wichita Falls
- Age
- 18 years and over
- People
- 736 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07365995 · EU 2025-524445-27-00 - Phase 2Taking peopleMultitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 52
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07574541 - Phase 1/2Taking peopleDocetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 120
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07667400 - Phase 1/2Not yet taking people in United StatesSTAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 67
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07902921 - Phase 2Taking peopleCarboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Where
- Ann Arbor, Aurora, Bay Pines, Boise, Chicago, Decatur, Durham, Kansas City, Madison, Minneapolis, New York, Orlando, Philadelphia, Portland, Seattle, The Bronx, Washington D.C., West Los Angeles
- Age
- 18 years and over
- People
- 100
- Run by
- VA Office of Research and Development
See details and how to joinNCT04038502 - Phase 2Taking peopleHigh Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Where
- Aurora, Charleston, Decatur, Durham, Gainesville, Houston, Kansas City, Louisville, Madison, Memphis, Nashville, Orlando, Portland, Salisbury, Seattle, St Louis, West Haven
- Age
- 18 years and over
- People
- 51
- Run by
- VA Office of Research and Development
See details and how to joinNCT05011383 - No phaseTaking peopleProstate Cancer IMAGing IN Early Detection (IMAGINED Trial)
- Where
- La Jolla
- People
- 225
- Run by
- University of California, San Diego
See details and how to joinNCT05882253 - Phase 3Not yet taking people in United StatesMultiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 300
- Run by
- Thomas Jefferson University
See details and how to joinNCT06024772 - Phase 2Taking peopleFolate Study in Men With Advanced Prostate Cancer
- Where
- La Jolla
- Age
- 18 years and over
- People
- 50
- Run by
- University of California, San Diego
See details and how to joinNCT06536374 - Phase 1/2Taking peopleA Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
- Where
- Fairfax, Lake Success, Nashville
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07730021 · EU 2026-525938-31-00 - Phase 2Taking peopleRadiation Therapy Approaches for People With Prostate Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 126
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07751159 - Phase 1Taking peopleA Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Where
- Anaheim, Austin, Boston, Dallas, Duarte, Fairfax, Fairway, Hackensack, Irving, Kansas City, Louisville, Myrtle Beach, Nashville, Newton, Norwalk, Oklahoma City, Omaha, Overland Park, Port Angeles, Poulsbo, Rockville, San Antonio, Seattle, Tucson, Westwood
- Age
- 18 years and over
- People
- 453 worldwide
- Run by
- Pfizer
See details and how to joinNCT03460977 · EU 2023-509179-18-00 - Phase 3Taking peopleTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Where
- Aberdeen, Alton, Altoona, Anchorage, Antigo, Arroyo Grande, Aurora, Baltimore, Bath, Baton Rouge, Bay Shore, Beaver, Bellingham, Bend, Bethesda, Biddeford, Billings, Bloomington, Boise, Bolivar, Boulder, Bozeman, Broomall, Burbank, Burnsville, Caldwell, Camden, Canton, Cape Girardeau, Carbondale, Carlisle, Carmichael, Carterville, Carthage, Cedar Rapids, Centralia, Charleston, Charlottesville, Chaska, Cheyenne, Chicago, Cincinnati, City of Saint Peters, Clackamas, Coeur d'Alene, Colorado Springs, Columbus, Coon Rapids, Coos Bay, Corona, Creve Coeur, Dallas, Danville, Decatur, DeKalb, Denver, Dillon, Dixon, Drexel Hill, Duarte, East Norriton, Eau Claire, Edina, Edmonds, Edwards, Effingham, Elk Grove, Encinitas, Englewood, Erie, Eureka, Everett, Fairbanks, Farmington, Farrell, Forest Hills, Fort Smith, Fort Worth, Fridley, Fruitland, Furlong, Galesburg, Garden City, Geneva, Glen Burnie, Glen Mills, Great Bend, Great Falls, Greensburg, Grenada, Gresham, Hackensack, Harrisburg, Havre, Hershey, Issaquah, Jackson, Jefferson City, Johnson Creek, Johnstown, Joplin, Kalispell, Kearney, Kenansville, Kennewick, Kewanee, Kinston, Lacey, La Jolla, Lake Success, Lakewood, Lancaster, Lexington, Lisle, Littleton, Longmont, Longview, Los Angeles, Louisville, Macomb, Madison, Maple Grove, Maplewood, Marshfield, Mattoon, Maywood, Mechanicsburg, Merced, Meridian, Minneapolis, Minocqua, Missoula, Monroeville, Monticello, Moon Township, Mount Vernon, Nampa, Natrona Heights, New Albany, Newberg, New Brunswick, New Castle, New Richmond, New York, Oak Brook, Oak Park, O'Fallon, Oklahoma City, Omaha, Oregon City, Orland Park, Osage Beach, Ottawa, Oxford, Palo Alto, Parker, Pekin, Peoria, Peru, Philadelphia, Phoenix, Pittsburg, Pittsburgh, Portland, Post Falls, Princeton, Pueblo, Rego Park, Rhinelander, Rice Lake, Richardson, Richlands, Richmond, Robbinsdale, Rockford, Rocklin, Rolla, Sacramento, Saint Cloud, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, San Antonio, San Diego, Sanford, San Luis Obispo, Santa Maria, Scarborough, Seattle, Sedro-Woolley, Seneca, Shakopee, Sheridan, Silverdale, Sioux Falls, Sleepy Hollow, Somerville, South Pasadena, South Portland, Spokane, Springfield, Stevens Point, Stillwater, St Louis, Stockton, Stony Brook, Sullivan, Tampa, The Bronx, Thornton, Toms River, Tualatin, Twin Falls, Uniontown, Upland, Urbana, Valhalla, Vancouver, Voorhees Township, Waconia, Walla Walla, Walnut Creek, Warrenville, Washington, Washington D.C., Wausau, Wesley Chapel, West Chester, Westminster, Weston, Williamsport, Willmar, Wisconsin Rapids, Woodbury, Woodland, York
- Age
- 18 years and over
- People
- 804
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT04423211 - No phaseTaking peopleThe Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
- Where
- Boston
- Age
- 55 years to 69 years
- People
- 5,000
- Run by
- VA Office of Research and Development
See details and how to joinNCT05926102 - Phase 3Taking peopleStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Aberdeen, Aurora, Austin, Baltimore, Charleston, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Fort Myers, Hattiesburg, Highlands Ranch, Houston, Iowa City, Lakewood, Las Vegas, Lexington, Lone Tree, Marshall, Miami, Milwaukee, Minneapolis, Mitchell, Morristown, Nashville, New Brunswick, New Haven, New Orleans, Omaha, Orange, Palo Alto, Pierre, Pittsburgh, Portland, Richmond, Riverside, Roanoke, Saint Louis Park, Seattle, Sioux Falls, St Louis, The Bronx, Yankton
- Age
- 18 years and over
- People
- 1,310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00 - Phase 1/2Taking peopleTulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Where
- Birmingham, Charleston, Durham, Iowa City, Myrtle Beach, Salt Lake City, Westwood, Wichita
- Age
- 18 years and over
- People
- 181 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07190300 · EU 2025-521873-15-00 - Phase 2Taking peopleTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Where
- Aberdeen, Aitkin, Alcoa, Allentown, Alton, Ames, Anaconda, Anchorage, Ankeny, Ann Arbor, Arroyo Grande, Ashland, Atlanta, Aurora, Aventura, Baker City, Ballwin, Baltimore, Bardstown, Basking Ridge, Baton Rouge, Beavercreek, Bellevue, Bellingham, Belpre, Bend, Bethesda, Bethlehem, Bettendorf, Billings, Birmingham, Bloomington, Boardman, Boise, Bolivar, Bonne Terre, Boone, Bozeman, Brainerd, Branson, Brighton, Brooklyn, Brownstown, Bryan, Buffalo, Burbank, Burien, Burlington, Burnsville, Burr Ridge, Caldwell, Cambridge, Canton, Cape Girardeau, Carbondale, Caro, Carson City, Carterville, Carthage, Centerville, Centralia, Chanute, Chapel Hill, Charleston, Chelsea, Chicago, Chillicothe, Cincinnati, City of Saint Peters, Clackamas, Clarkston, Clinton Township, Clive, Clovis, Cody, Coeur d'Alene, Colorado Springs, Columbus, Commack, Coon Rapids, Coos Bay, Corbin, Council Bluffs, Covington, Creston, Creve Coeur, Cudahy, Dallas, Danville, Dayton, Dearborn, Decatur, Deer River, Delaware, Denver, Des Moines, Detroit, Detroit Lakes, Dixon, Dodge City, Dublin, Duluth, Durango, East China Township, East Stroudsburg, Eau Claire, Edina, Edmonds, Effingham, El Dorado, Emeryville, Emmett, Enumclaw, Erie, Eureka, Everett, Fairway, Fargo, Farmington, Federal Way, Fergus Falls, Findlay, Flint, Fort Dodge, Fort Lauderdale, Fort Smith, Fort Worth, Fosston, Franklin, Frederick, Fridley, Fruitland, Gahanna, Galesburg, Garden City, Germantown, Grafton, Grand Island, Great Bend, Great Falls, Green Bay, Greenbrae, Greensburg, Greenville, Grosse Pointe Woods, Grove City, Harrison, Hays, Hazleton, Helena, Henderson, Hendersonville, Hibbing, Homer Glen, Hot Springs, Independence, Iowa City, Issaquah, Jackson, Jamestown, Jefferson, Jefferson City, Jefferson Hills, Johns Creek, Joplin, Kalispell, Kansas City, Kearney, Kenner, Kennewick, Kenosha, Kettering, Kewanee, Kingman, Knoxville, Lacey, Lake Forest, Lake Success, Lakewood, Lancaster, Lansing, Las Vegas, Lawrence, Lawton, Lee's Summit, Lexington, Liberal, Lima, Lincoln, Littleton, Livonia, London, Longmont, Longview, Los Angeles, Louisville, Macomb, Manhattan, Mansfield, Maple Grove, Maplewood, Marietta, Marinette, Marion, Marlette, Marshalltown, Marshfield, Martinez, Marysville, Mattoon, Maywood, McPherson, Melrose Park, Meridian, Metairie, Miami Beach, Middletown, Milwaukee, Mineola, Minneapolis, Minocqua, Missoula, Monroeville, Monticello, Montvale, Mount Vernon, Mukwonago, Nampa, Nashville, Natrona Heights, Newark, Newberg, New Lenox, New Orleans, Newport Beach, New Richmond, Newton, New Ulm, New York, N. Huntingdon, Novi, Oakland, Oak Park, Oconomowoc, O'Fallon, Oklahoma City, Olathe, Omaha, Ontario, Oregon City, Orlando, Orland Park, Oshkosh, Ottawa, Pahrump, Papillion, Parker, Park Rapids, Parsons, Peabody, Pekin, Peoria, Perrysburg, Peru, Phoenix, Pittsburg, Pittsburgh, Pontiac, Port Huron, Portland, Portsmouth, Post Falls, Poulsbo, Pratt, Princeton, Pueblo, Racine, Redmond, Reno, Renton, Rice Lake, Richardson, Richmond, Robbinsdale, Rochester, Rochester Hills, Rolla, Saginaw, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, Salina, Sandpoint, Sandstone, San Luis Obispo, Santa Maria, Scottsdale, Seattle, Sedro-Woolley, Shakopee, Sheboygan, Shelby, Shelton, Shepherdsville, Sheridan, Shiloh, Silverdale, Springfield, Sterling Heights, Stevens Point, Stillwater, St Louis, Sullivan, Summit, Swansea, Syracuse, Tacoma, Tawas City, Toledo, Topeka, Troy, Tucson, Tulsa, Twin Falls, Two Rivers, Uniondale, Urbana, Vancouver, Virginia, Waconia, Walla Walla, Walnut Creek, Warren, Washington, Washington D.C., Waukee, Waukesha, Wauwatosa, Wellington, West Allis, West Bloomfield, West Branch, West Chester, West Des Moines, Westerville, Weston, Westwood, Wexford, Wichita, Willmar, Winchester, Winfield, Woodbury, Wyandotte, Wyoming, Yakima, Yelm, Yorkville, Youngstown, Ypsilanti, Zanesville
- Age
- 18 years and over
- People
- 314 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03866382 - Phase 1Taking peopleStudy of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Atlanta, Cincinnati, Denver, Duarte, Durham, Fairfax, Fullerton, Greenville, Houston, Indianapolis, Irving, Kansas City, Murray, New York, Philadelphia, Pittsburgh, Rochester, San Francisco, Seattle, Sioux Falls, St Louis, Winston-Salem
- Age
- 18 years and over
- People
- 505 worldwide
- Run by
- Amgen
See details and how to joinNCT04221542 · EU 2023-504361-23-00 - Phase 2Taking peopleAn Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05454488 - Phase 2Taking peopleTesting the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- Where
- Baltimore, Chicago, Columbus, Dallas, Duarte, Houston, Lexington, Los Angeles, Madison, Sacramento, Winston-Salem
- Age
- 18 years and over
- People
- 35
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05691465 - No phaseTaking peopleSacral Neuromodulation for Male Overactive Bladder (MOAB)
- Where
- Annapolis, Arlington, Bala-Cynwyd, Birmingham, Cleveland, Detroit, Fairhope, Houston, Miami, Mountain View, Murrieta, New Orleans, New York, North Charleston, Orlando, Oxford, Raleigh, Rochester, San Francisco, Scottsdale, Shreveport, Tulsa, Woodbridge
- Age
- 18 years and over
- People
- 150
- Run by
- Axonics, Inc.
See details and how to joinNCT06511141 - Phase 2Taking peoplePhase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06567314 - No phaseEnrolling by invitationMediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 25
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06935097